These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10237848)

  • 21. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling.
    Robinson DS
    Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625
    [No Abstract]   [Full Text] [Related]  

  • 22. [Liability for drug-related damage by the pharmaceutical industry and the physician].
    Dahse G
    Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639
    [No Abstract]   [Full Text] [Related]  

  • 23. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 24. An update on the therapeutic orphan.
    Wilson JT
    Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
    [No Abstract]   [Full Text] [Related]  

  • 25. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule.
    Connor JD
    Pediatrics; 1999 Sep; 104(3 Pt 2):610-3. PubMed ID: 10469801
    [No Abstract]   [Full Text] [Related]  

  • 26. When you have a hammer everything looks like a nail: misapplication of the False Claims Act to off-label promotion.
    Hall RF; Berlin RJ
    Food Drug Law J; 2006; 61(4):653-77. PubMed ID: 17180768
    [No Abstract]   [Full Text] [Related]  

  • 27. Comments on the American Pharmaceutical Association on proposed rulemakings.
    J Am Pharm Assoc; 1975 Mar; 15(3):139-44. PubMed ID: 1092750
    [No Abstract]   [Full Text] [Related]  

  • 28. Adoption of orphan products by the pharmaceutical industry.
    Finkel MJ
    N Engl J Med; 1984 Sep; 311(10):677-8. PubMed ID: 6472354
    [No Abstract]   [Full Text] [Related]  

  • 29. The "Long" amendment.
    Provost GP
    Am J Hosp Pharm; 1967 Dec; 24(12):665. PubMed ID: 6073365
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical global marketing practices: increased scrutiny ahead?
    Hack EI
    Food Drug Law J; 2007; 62(2):343-8. PubMed ID: 17632965
    [No Abstract]   [Full Text] [Related]  

  • 31. A survey of developments in food and drug law from July 1998 to November 1999.
    Littlefield N; Hada NR
    Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
    [No Abstract]   [Full Text] [Related]  

  • 32. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI
    Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
    [No Abstract]   [Full Text] [Related]  

  • 33. Off-label drug use.
    Dooley AG
    Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 35. APhA government affairs annual report.
    Am Pharm; 1987 Feb; NS27(2):35-8. PubMed ID: 3565249
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: Drugs anonymous?
    Feldmann EG
    J Pharm Sci; 1974 Nov; 63(11):I. PubMed ID: 4427222
    [No Abstract]   [Full Text] [Related]  

  • 37. Counterfeit drugs arise from various sources.
    Thompson CA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1506, 1511. PubMed ID: 12951748
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

  • 39. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 40. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.